AnaptysBio, Inc. ANAB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$52.88M-34.5% | —— | $15.11M+146% | -$38.63M+17.2% | -$39.33M+10.5% | ||
| $130K-11.0% | $131K-9.7% | $140K-2.8% | $142K-7.8% | $146K-10.4% | ||
| $14.22M+55.0% | $8.51M+3.9% | $9.16M+11.8% | $9.24M+22.5% | $9.17M-9.5% | ||
| -$0+100% | —— | —— | —— | -$3.54M— | ||
| -$17.82M+25.9% | -$22.41M+44.0% | -$18.56M-652% | -$22.32M-378% | -$24.03M-365% | ||
| -$1.5M-183% | -$971K-225% | —— | -$414K+86.5% | -$530K-134% | ||
| -$8.1M+64.6% | —— | -$22.52M-46.1% | -$14.79M-35.0% | -$22.88M-262% | ||
| $8K-99.5% | $340K-85.2% | $1.13M-56.0% | $1.6M-35.5% | $1.67M-43.8% | ||
| $480K+4.3% | $475K+4.2% | $470K+4.0% | $459K+4.1% | $460K+4.1% | ||
| -$499K-8.0% | -$494K-8.1% | -$490K-8.4% | -$479K-8.4% | -$462K-8.5% | ||
| -$25.92M-142% | $98M+247% | -$27.36M-171% | -$40.24M-88.7% | -$10.7M+71.3% | ||
| $17K-51.4% | $1K-99.6% | $12K-65.7% | $39K+18.2% | $35K+29.6% | ||
| $0-100% | $0-100% | $19.66M-61.7% | $54.21M-63.7% | $122.55M+108% | ||
| $35M-74.5% | $73.5M-19.9% | $122.95M+11.8% | $90.65M-38.2% | $137.43M+7.7% | ||
| $34.98M+136% | $73.5M— | $103.28M+76.2% | $36.4M— | $14.85M-78.4% | ||
| $0-100% | $3.38M+642% | $9.72M— | $51.1M— | $4.42M— | ||
| $14.02M+4,735% | $12.21M+2,100% | $336K-91.9% | $1.42M+45.4% | $290K-64.2% | ||
| $0-100% | —— | —— | —— | $1.45M-80.7% | ||
| $1.21M+104% | -$43.13M-256% | -$10.39M-115% | -$50.5M-221% | -$28.59M-110% | ||
| $10.27M+142% | $128.36M— | $65.54M-45.3% | -$54.34M-400% | -$24.44M-238% | ||
| $20.83M+15.1% | $23.07M-45.3% | $21.03M— | $17.8M— | $18.1M— | ||
| -$8.1M+64.6% | -$41.84M-246% | $54.27M+1,602% | —— | -$22.88M-9,714% | ||
| -$0+100% | —— | —— | —— | -$3.54M— | ||
| -$499K-8.0% | -$494K-8.1% | -$490K-8.4% | -$479K-8.4% | -$462K-8.5% | ||
| -$1.5M-183% | -$971K-225% | —— | -$414K+86.5% | -$530K-134% | ||
| $20.86M+15.5% | —— | —— | —— | $18.06M+44.2% | ||
| $480K+4.3% | $475K+4.2% | $470K+4.0% | $459K+4.1% | $460K+4.1% | ||
| $35M-74.5% | $73.5M-19.9% | $122.95M+11.8% | $90.65M-38.2% | $137.43M+7.7% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $12.81M-44.3% | $51.96M— | $1.01M-96.2% | $823K-90.9% | $23.01M+231% | ||
| $23K+109% | $0-100% | —— | —— | $11K— | ||
| -$499K-8.0% | -$494K-8.1% | -$490K-8.4% | -$479K-8.4% | -$462K-8.5% | ||
| $8K-99.5% | $340K-85.2% | $1.13M-56.0% | $1.6M-35.5% | $1.67M-43.8% | ||
| $40K+700% | —— | —— | —— | $5K— | ||
| $304K— | —— | $452K+1,659% | $0-100% | $0— | ||
| $0-100% | —— | $74K— | —— | $959K— | ||
| -$25.94M-142% | $98M+246% | -$27.37M-170% | -$40.28M-88.6% | -$10.74M+71.2% | ||
| -$25.94M-142% | $98M+246% | -$27.37M-170% | -$40.28M-88.6% | -$10.74M+71.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AnaptysBio, Inc. generate?
- AnaptysBio, Inc. (ANAB) generated $4.5M in operating cash flow over the trailing twelve months.
- What is AnaptysBio, Inc.'s free cash flow?
- After $69.0K of capital expenditures, AnaptysBio, Inc.'s free cash flow was $4.4M over the trailing twelve months, up 104.0% year over year.
- Where does AnaptysBio, Inc.'s cash flow data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
